BDBM579319 US11479560, Title ww6-266::US11479560, Title ww6-268-second::US11479560, Title ww7-31::US11479560, Title ww7-32::US11479560, Title ww7-39::US11479560, Title ww7-40

SMILES CC(c1ccc(C)cc1)n1c2cccnc2n(C(Cc2ccc(C)cc2)C(O)CC#N)c1=N

InChI Key InChIKey=UIZJPHUNRVBOFJ-UHFFFAOYSA-N

Data  6 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 579319   

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579319(US11479560, Title ww6-266 | US11479560, Title ww7-...)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579319(US11479560, Title ww6-266 | US11479560, Title ww7-...)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579319(US11479560, Title ww6-266 | US11479560, Title ww7-...)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579319(US11479560, Title ww6-266 | US11479560, Title ww7-...)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579319(US11479560, Title ww6-266 | US11479560, Title ww7-...)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
University ff Texas System

US Patent
LigandPNGBDBM579319(US11479560, Title ww6-266 | US11479560, Title ww7-...)
Affinity DataEC50: >1.00E+3nMAssay Description:HEK293 cells stably expressing OX2R are transfected with Gq alpha construct (6.4 ug per 10 cm dish) using Lipofectamine 3000 (ThermoFisher). 24 hours...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent